Medical
The companies featured on PressReleaseFinder are active in several industries.
The companies featured on PressReleaseFinder are active in several industries.
24 Nov 2010
Perfect infrastructure in the border triangle of Switzerland-Germany-France
Particularly appealing for companies in the chemicals and life science industries
Clariant-Switzerland’s Country Manager Spitz: excellent opportunities for the Muttenz location
4 Nov 2010
Muttenz, November 4, 2010 - Designers and manufacturers looking to add a distinctive aesthetic touch to pharmaceutical packaging and medical devices can trust new MEVOPUR® color masterbatches and compounds from Clariant Masterbatches for creative colors.
4 Nov 2010
Muttenz, November 4, 2010 - In today’s competitive marketplace manufacturers must try to differentiate their product from others by improving functionality and design. Use of drug delivery devices increasingly occurs outside of a hospital setting and since it is the patient rather than a doctor who is the user, the device must be attractive as well as convenient and functional. They become more like any other consumer product. That is why color and other visual elements are increasingly important in device design.
29 Apr 2010
• Sales up 16% in local currencies and 13% in CHF on the back of improved demand
• Operating income before exceptional items rose to CHF 183 million compared to CHF –13 million a year ago on higher capacity utilization and lower costs
• Operating income margin before exceptional items reached 10.1%
• Cash flow from operations reached CHF 159 million after CHF 156 million in the first quarter 2009
• Outlook: For the full-year, Clariant expects sales in local currencies to increase in the mid single-digit range and an operating margin before exceptional items above the 2008 level of 6.6%. Cash flow from operations will remain strong.
16 Feb 2010
• Sales in 2009 down 14% in local currency and 18% in CHF
• Operating income before exceptional items decreased to CHF 270 million in 2009 from CHF 530 million in 2008
• Cash flow from operations improved to CHF 757 million from CHF 391 million in the previous year
• Net debt reduced to CHF 545 million from CHF 1,209 million in 2008
• As part of the ongoing asset network optimization program, further measures are being implemented, affecting production sites in Muttenz (Switzerland), Resende (Brazil) and Thane (India)
• Outlook 2010: Clariant does not foresee a sustainable recovery of the global economy. As a consequence, Clariant expects sales growth in local currencies in the low single-digit range. The operating income margin before exceptionals is expected to rise above 6%. Cash flow from operations will remain strong but below the levels of 2009.
9 Feb 2010
Muttenz, February 9, 2010 - Clariant Masterbatches presents the latest in its color and performance-enhancing materials designed to bring cutting-edge functionality and aesthetics to medical devices and pharmaceutical packaging at MD&M West 2010.
The companies featured on PressReleaseFinder are active in several industries. If you are interested in a specific industry, please select one to filter the available press releases.
Additives
Adhesives
Agriculture
Architecture
Automation
Automotive
Aviation
Beverage
Biotechnology
Building and Construction
Catalysts
Chemicals
Coatings
Composites
Consumer Goods
Defense
Electrical
Energy & Power
Engineering
Environment
Flooring
Food
Furniture
Glass
Healthcare
Home and Household Care
HVAC
Industrial
Logistics
Lubricants
Machinery
Marine
Medical
Metals
Military
Mining
Packaging
Paper
Personal Care
Petrochemicals
Pharmaceuticals
Pipes & Tubes
Plastics
Polymers
Printing
Recycling
Retail
Rubber
Semiconductors
Sports
Textiles
Transportation
Water Management
Wire & Cable
Woodworking